Evidence and unresolved questions in pulmonary hypertension: Insights from the 5th French Pulmonary Hypertension Network Meeting

IF 2.2 4区 医学 Q3 RESPIRATORY SYSTEM Respiratory Medicine and Research Pub Date : 2024-06-22 DOI:10.1016/j.resmer.2024.101123
Athénaïs Boucly , Laurent Bertoletti , Charles Fauvel , Mélanie Gallant Dewavrin , Christian Gerges , Julien Grynblat , Christophe Guignabert , Sébastien Hascoet , Xavier Jaïs , Etienne-Marie Jutant , Nicolas Lamblin , Olivier Meyrignac , Marianne Riou , Laurent Savale , Cécile Tromeur , Ségolène Turquier , Simon Valentin , Gérald Simonneau , Marc Humbert , Olivier Sitbon , David Montani
{"title":"Evidence and unresolved questions in pulmonary hypertension: Insights from the 5th French Pulmonary Hypertension Network Meeting","authors":"Athénaïs Boucly ,&nbsp;Laurent Bertoletti ,&nbsp;Charles Fauvel ,&nbsp;Mélanie Gallant Dewavrin ,&nbsp;Christian Gerges ,&nbsp;Julien Grynblat ,&nbsp;Christophe Guignabert ,&nbsp;Sébastien Hascoet ,&nbsp;Xavier Jaïs ,&nbsp;Etienne-Marie Jutant ,&nbsp;Nicolas Lamblin ,&nbsp;Olivier Meyrignac ,&nbsp;Marianne Riou ,&nbsp;Laurent Savale ,&nbsp;Cécile Tromeur ,&nbsp;Ségolène Turquier ,&nbsp;Simon Valentin ,&nbsp;Gérald Simonneau ,&nbsp;Marc Humbert ,&nbsp;Olivier Sitbon ,&nbsp;David Montani","doi":"10.1016/j.resmer.2024.101123","DOIUrl":null,"url":null,"abstract":"<div><p>Pulmonary hypertension (PH) continues to present significant challenges to the medical community, both in terms of diagnosis and treatment. The advent of the updated 2022 European Society of Cardiology (ESC) and European Respiratory Society (ERS) guidelines has introduced pivotal changes that reflect the rapidly advancing understanding of this complex disease. These changes include a revised definition of PH, updates to the classification system, and treatment algorithm. While these guidelines offer a critical framework for the management of PH, they have also sparked new discussions and questions. The 5th French Pulmonary Hypertension Network Meeting (Le Kremlin-Bicêtre, France, 2023), addressed these emergent questions and fostering a deeper understanding of the disease's multifaceted nature. These discussions were not limited to theoretical advancements but extended into the practical realms of patient management, highlighting the challenges and opportunities in applying the latest guidelines to clinical practice.</p></div>","PeriodicalId":48479,"journal":{"name":"Respiratory Medicine and Research","volume":"86 ","pages":"Article 101123"},"PeriodicalIF":2.2000,"publicationDate":"2024-06-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Respiratory Medicine and Research","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590041224000394","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0

Abstract

Pulmonary hypertension (PH) continues to present significant challenges to the medical community, both in terms of diagnosis and treatment. The advent of the updated 2022 European Society of Cardiology (ESC) and European Respiratory Society (ERS) guidelines has introduced pivotal changes that reflect the rapidly advancing understanding of this complex disease. These changes include a revised definition of PH, updates to the classification system, and treatment algorithm. While these guidelines offer a critical framework for the management of PH, they have also sparked new discussions and questions. The 5th French Pulmonary Hypertension Network Meeting (Le Kremlin-Bicêtre, France, 2023), addressed these emergent questions and fostering a deeper understanding of the disease's multifaceted nature. These discussions were not limited to theoretical advancements but extended into the practical realms of patient management, highlighting the challenges and opportunities in applying the latest guidelines to clinical practice.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
肺动脉高压的证据和悬而未决的问题:第五届法国肺动脉高压网络会议的启示。
肺动脉高压(PH)在诊断和治疗两方面都给医学界带来了巨大挑战。2022 年更新的欧洲心脏病学会(ESC)和欧洲呼吸学会(ERS)指南的问世带来了关键性的变化,反映出人们对这种复杂疾病的认识正在迅速发展。这些变化包括修订 PH 的定义、更新分类系统和治疗算法。这些指南为 PH 的治疗提供了重要框架,同时也引发了新的讨论和问题。第五届法国肺动脉高压网络会议(2023 年,法国 Le Kremlin-Bicêtre)讨论了这些新出现的问题,并促进了对该疾病多面性的深入了解。这些讨论并不局限于理论上的进步,而是延伸到患者管理的实际领域,强调了将最新指南应用于临床实践的挑战和机遇。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Respiratory Medicine and Research
Respiratory Medicine and Research RESPIRATORY SYSTEM-
CiteScore
2.70
自引率
0.00%
发文量
82
审稿时长
50 days
期刊最新文献
Tele-medicine experiences and expectations from patients with neuromuscular diseases treated with non-invasive ventilation The role of high flow nasal oxygen therapy in acute hypoxemic respiratory failure due to COVID-19 pneumonia Role of narrow band imaging in assessing bronchial mucosal hypervascularization in COVID-19 patients Constraints to the initiation of home non-invasive ventilation and short-term efficacy in different diagnostic groups (as a prelude to an ambulatory shift) Pulmonary hypertension in patients with chronic obstructive pulmonary disease: Impact of lung hyperinflation on the response to pulmonary hypertension treatment
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1